Gestrinone compared with mifepristone for emergency contraception: A randomized controlled trial

Obstetrics and Gynecology

Volumn 115, Issue 4, 2010, Pages 740-744

  Godfrey, Emily M ^a   Wu, Shangchun ^b   Dong, Jing ^b   Cong, Jie ^b   Wang, Cuiping ^b   Vonhertzen, Helena ^b  

^a UNIVERSITY OF ILLINOIS   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GESTRINONE; MIFEPRISTONE; PLACEBO;

ADULT; ARTICLE; BLEEDING; BREAST TENDERNESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; EMERGENCY CONTRACEPTION; FAMILY PLANNING; FATIGUE; FEMALE; HUMAN; LOWER ABDOMINAL PAIN; MENSTRUAL CYCLE; MULTICENTER STUDY; NAUSEA; NORMAL HUMAN; PREGNANCY RATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; SPOTTING; UNPLANNED PREGNANCY; VOMITING;

ABORTIFACIENT AGENTS, STEROIDAL; CONTRACEPTION, POSTCOITAL; DOUBLE-BLIND METHOD; FEMALE; GESTRINONE; HUMANS; MIFEPRISTONE; PREGNANCY; TREATMENT OUTCOME;

EID: 77949901823     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3181d43ae4     Document Type: Article

References (15)

1. von Hertzen H, Piaggio G, Ding J, Chen J, Song S, Bártfai G, et al. Low dose mifepristone and two regimens of levonorg-estrel for emergency contraception: a WHO multicentre randomised trial. Lancet 2002;360:1803-1810
2. Glasier A, Thong KJ, Dewar M, Mackie M, Baird DT. Mifepristone (RU 486) compared with high-dose estrogen and progestogen for emergency postcoital contraception. N Engl J Med 1992;327:1041-1044
3. Comparison of three single doses of mifepristone as emergency contraception: a randomised trial. Task Force on Postovulatory Methods of Fertility Regulation. Lancet 1999;353:697-702.
4. Markiewicz L, Hochberg RB, Gurpide E. Intrinsic estrogenic-ity of some progestagenic drugs. J Steroid Biochem Mol Biol 1992;41:53-58
5. Verma U, Laumas KR. Screening of anti-progestins using in vitro human uterine progesterone receptor assay system. J Steroid Biochem 1981;14:733-740
6. Hornstein MD, Gleason RE, Barbieri RL. A randomized double-blind prospective trial of two doses of gestrinone in the treatment of endometriosis. Fertil Steril 1990;53:237-241
7. Vercellini P, Somigliana E, Viganò P, Abbiati A, Daguati R, Crosignani PG. Endometriosis: current and future medical therapies. Best Pract Res Clin Obstet Gynaecol 2008;22: 275-306.
8. David SS, Huggins GR, Garcia CR, Busacca C. A synthetic steroid (R2323) as a once-a-week oral contraceptive. Fertil Steril 1979;31:278-281
9. Sakiz E, Azadian-Boulanger G, Ojasoo T, Laraque F. Contraceptive efficacy of once-weekly oral administration of 2.5 mg R 2323. Contraception 1976;14:275-284
10. Jiang D, Wu E. Effects of gestrinone (R2323) on emergency contraception: a clinical observation of 120 cases. J Reprod Med (in Chinese) 2002;11:326-330
11. Gao X, Wu E, Chen G. Mechanism of emergency contraception with gestrinone: a preliminary investigation. Contraception 2007;76:221-227
12. Dixon GW, Schlesselman JJ, Ory HW, Blye RP. Ethinyl estradiol and conjugated estrogens as postcoital contraceptives. JAMA 1980;244:1336-1339
13. Trussell J, Ellertson C, von Hertzen H, Bigrigg A, Webb A, Evans M, et al. Estimating the effectiveness of emergency contraceptive pills. Contraception 2003;67:259-265
14. International Consortium for Emergency Contraception. EC status and availability. Available at http://www.cecinfo.org/ database/pill/viewAllCountry. php. Retrieved September 11, 2009.
15. Creinin MD, Schlaff W, Archer DF, Wan L, Frezieres R, Thomas M, et al. Progesterone receptor modulator for emergency contraception: a randomized controlled trial. Obstet Gynecol 2006;108:1089-1097